Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Triple-Blind, Double-Dummy, Placebo-Controlled, Parallel Groups, Outpatient Study to Examine the Safety and Efficacy of MK0462 10 mg p.o. and MK0462 5 mg p.o. for the Treatment of Acute Migraine and Migraine Recurrence

NCT00897949 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT00897949
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00897949 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Triple-Blind, Double-Dummy, Placebo-Controlled, Parallel Groups, Outpatient Study to Examine the Safety and Efficacy of MK0462 10 mg p.o. and MK0462 5 mg p.o. for the Treatment of Acute Migraine and Migraine Recurrence
Lead sponsor
Organon and Co
Phase
Phase 3
Overall status
Completed
Start date
March 31, 1995
Completion date
July 31, 1996
Enrollment
1,473 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

migraine headache